Drug intelligence / Profile preview

Congestyl

Development stage
Phase 3
Lead developer
Meyer Organics
Modality
Small Molecules
Administration
Oral
01

Overview

**Congestyl** is an oral fixed-dose cold-and-flu medicine marketed by Meyer Organics as an uncoated tablet containing paracetamol 500 mg, phenylephrine hydrochloride 5 mg, and chlorpheniramine maleate 4 mg. It is intended for symptomatic relief of common-cold and upper-respiratory allergy symptoms, including fever, pain or headache, rhinorrhea, sneezing, and nasal congestion. Paracetamol provides analgesic and antipyretic effects; phenylephrine is a sympathomimetic nasal decongestant; and chlorpheniramine is a first-generation histamine H1-receptor antagonist with anti-allergic activity.

Brand names
Congestyl
Other names
acetaminophen + phenylephrine HCl + chlorpheniramine maleateacetaminophen/chlorpheniramine/phenylephrine
02

Targets

ADRA1A (α1A)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Congestyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Congestyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call